Statins for Treating Alzheimer's Disease: Truly Ineffective?
Ting Liang1, Rong Li, Oumei Cheng
1Department of Neurology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
European Neurology
|May 30, 2015
Summary
Statins show no significant benefit for Alzheimer's disease (AD) patients in clinical trials. While well-tolerated, further research is needed to assess their efficacy in AD with vascular risk factors.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Trials
Background:
- Animal studies suggest statins may protect against Alzheimer's disease (AD).
- However, clinical trial results have been inconsistent, necessitating further investigation.
Purpose of the Study:
- To evaluate the efficacy and safety of statins in treating Alzheimer's disease (AD).
Main Methods:
- A meta-analysis of double-blind, randomized controlled trials was conducted.
- Searched major databases (PubMed, Cochrane, EMBASE, etc.) for relevant studies.
- Assessed outcomes including cognitive function (MMSE, ADAS-Cog) and functional status, alongside safety measures.
Main Results:
- Four studies with 1,127 participants diagnosed with probable or possible AD were analyzed.
- No significant differences were found between statin and placebo groups for primary or secondary outcomes.
- Adverse events and laboratory abnormalities did not differ significantly between groups.
Conclusions:
- Statins are well-tolerated in AD patients with no unexpected adverse events.
- The current evidence does not support the efficacy of statins for AD treatment.
- More research is required to determine statin effectiveness in AD patients with vascular risk factors.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:26Atherosclerosis III: Management
602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
895
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
895
01:23Atherosclerosis IV: Nursing Management
588
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
588